Cargando…
Reconstituting Immune Surveillance in Breast Cancer: Molecular Pathophysiology and Current Immunotherapy Strategies
Over the past 50 years, breast cancer immunotherapy has emerged as an active field of research, generating novel, targeted treatments for the disease. Immunotherapies carry enormous potential to improve survival in breast cancer, particularly for the subtypes carrying the poorest prognoses. Here, we...
Autores principales: | Cilibrasi, Chiara, Papanastasopoulos, Panagiotis, Samuels, Mark, Giamas, Georgios |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8584417/ https://www.ncbi.nlm.nih.gov/pubmed/34769447 http://dx.doi.org/10.3390/ijms222112015 |
Ejemplares similares
-
Extracellular Vesicles as Mediators of Therapy Resistance in the Breast Cancer Microenvironment
por: Samuels, Mark, et al.
Publicado: (2022) -
Incorporating Immunotherapy in the Management of Gastric Cancer: Molecular and Clinical Implications
por: Agnarelli, Alessandro, et al.
Publicado: (2022) -
The Inhibitory Properties of a Novel, Selective LMTK3 Kinase Inhibitor
por: Agnarelli, Alessandro, et al.
Publicado: (2023) -
Definition of an Inflammatory Biomarker Signature in Plasma-Derived Extracellular Vesicles of Glioblastoma Patients
por: Cilibrasi, Chiara, et al.
Publicado: (2022) -
Correction to: LMTK3 inhibition affects microtubule Stability
por: Cilibrasi, Chiara, et al.
Publicado: (2021)